Magnus Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.47 M
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.06 Cr
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth 74.09%
- Profit Growth 75.40%
- Ebitda 706.74%
- Net Worth 110.25%
- Total Assets 2.86%
About Magnus Biotech
Magnus Biotech Private Limited (MBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 January 2003 and has a history of 22 years and one month. Its registered office is in Karnal, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.47 M.
The company currently has active open charges totaling ₹6.06 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aman, Manish Kumar, and Lal Singh serve as directors at the Company.
Company Details
- Location
Karnal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231HR2003PTC035019
- Company No.
035019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Magnus Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aman  | Director | 27-Sep-2022 | Current |
| Manish Kumar | Director | 14-Aug-2023 | Current |
| Lal Singh | Director | 27-Jul-2022 | Current |
Financial Performance of Magnus Biotech.
Magnus Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.09% increase. The company also saw a substantial improvement in profitability, with a 75.4% increase in profit. The company's net worth Soared by an impressive increase of 110.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnus Biotech?
Unlock access to Magnus Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹60.63 M
₹30.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.00 Cr
- Others : 2.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2022 | Hdfc Bank Limited | ₹4.00 Cr | Open |
| 24 Jul 2020 | Others | ₹2.06 Cr | Open |
| 07 Mar 2011 | State Bank Of India | ₹3.00 M | Satisfied |
| 04 Mar 2010 | State Bank Of India | ₹2.10 Cr | Satisfied |
| 04 Mar 2010 | State Bank Of India | ₹6.00 M | Satisfied |
How Many Employees Work at Magnus Biotech?
Magnus Biotech has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
